Summary.-We have shown that thioamides are incorporated as false precursors into melanin during its synthesis. To be clinically useful in the diagnosis or therapy of melanotic melanomas, they would have to be tagged with an appropriate isotope or possibly a cytotoxic moiety. 125I-Thiouracil (125I-TU) is here shown to be accumulated in the melanin of melanotic melanomas transplanted into mice in a similar way as is 14C-thiouracil (14C-TU). 125I-TU gives tumour/liver and tumour/muscle ratios up to 22 and 778 respectively, at 4 days after administration. 125I -TU is accumulated by melanoma cells in vitro more effectively than 14C-TU (1251-TU/14C-TU, 2 7), while the in vivo accumulation into melanomas is slightly lower for 1251-TU as compared to 14C-TU (125I-TU/14C-TU, 035 ). This appears to be due to a partial deiodination (< 14% of the dose within 4 days) and probably a more rapid excretion of 125I-TU or its metabolite(s). The accumulation of radioactivity in the thyroid can essentially be eliminated by pretreatment with potassium iodide and/or thyroxine. 1251-Propylthiouracil is also accumulated in melanotic melanoma cells in vivo and in vitro, but at a lower level than in 1251 -TU and L4C -TU.
IN EARLIER STUDIES it was shown that
thiouracil and related thioamides, in addition to their accumulation in the thyroid, are also incorporated into melanin when this is synthesized, e.g. in the eyes of foetuses or young animals and in melaninproducing tumours (Whittaker, 1971; Dencker et al., 1979 Dencker et al., , 1981 Dencker et al., , 1982 . Unlike drugs such as chloroquine and chlorpromazine (Lindquist & Ullberg, 1972) , thiouracil does not bind to preformed melanin. If one is interested in finding drugs that might be clinically useful in localizing malignant melanomas, which usually have a high rate of melanin synthesis, then thioamides may be the drugs of choice.
To be clinically useful in this respect, the thioamides would have to be tagged with a gamma-emitting isotope with a relatively short half-life. Even if a number of different isotopes may prove useful, we have so far considered it most relevant to work with iodine, for which a number of isotopes are available.
The aim of this paper is to determine whether thiouracil labelled with iodine-125 is incorporated into melanotic melanoma cells in vitro and in vivo similarly to thiouracil. In addition we have studied the effects of potassium iodide and thyroxine on the uptake of radioactivity in the thyroid after 1251-thiouracil dosing. We have been able to determine approximately the extent of deiodination of 1251-thiouracil in vivo. Finally we have also studied the distribution of 1251-labelled propylthiouracil.
MATERIALS AND METHODS

Chemicals
2-Thiouracil (TU) was purchased from Aldrich-Europe, Belgium, and 6-n-propyl-2-thiouracil (PTU) from Sigma, St Louis, MO, U.S.A. Na125I (approx. Visser & Klootwijk (1981) . The main deviation was that the labelling was made at pH 7-5 (instead of 3-3), in order to increase the yield. To 1 mCi 1251-(10 Pl) was added 10 ,ul 0-5M sodium acetate (pH 8-8), 2 jug TU in 10 Il ethanol and 20 ,ug chloramine-T in 10 ,ul 001M phosphate buffer (pH 7-4). The final pH of the mixture was 7-5. After 10 min, the reaction was stopped by the addition of 100 ,ug sodium metabisulphite in 50 ,ul 0-IM acetic acid. The separation of 1251-TU from the mixture was made on Sephadex GIO in a small Pasteur pipette. Twenty-mM acetic acid containing 0-1mM dithiothreitol was used for elution and storage. Two peaks were obtained: unreacted 1251-and l251-TU (60%). This is in agreement with the results of Visser & Klootwijk (1981) . The specific activity of the 1251-TU was calculated to be higher than 103 Ci/mmol.
5-1251-6-n-Propyl-2-thiouracil (125I-PT U). (Ullberg, 1954 (Ullberg, , 1977 . The sections were then freeze-dried and opposed against X-ray film for autoradiography (section thickness; 20 and 60 ,um).
Scintillation-counting experiments
Quantitative measurements were performed in different ways. Either tissues were scraped off from thick (200/tm) tapefastened sections or were dissected out at necropsy directly after killing. For 125J, the tissues were measured in a Packard AutoGamma scintillation spectrometer. For 14C, melanin-containing tissues were dissolved in Soluene-100 (Packard), bleached by the addition of 0-2 ml isopropanol and 0-2 ml of 35% H202 and incubated at 40°C for 30 min, after which 15 ml of Instagel was added. To the serum samples was added 1 ml of water and 10 ml of Instagel. Remaining tissues were dissolved in Soluene-350 (Packard), after which 10 ml of scintillation fluid (4-9 g PPO, 0-1 g dimethyl POPOP per 1 toluene) was added. The specimens were counted in a Packard Tricarb 460CD liquid scintillation spectrometer with the use of an external standard.
Experimental groups
Distribution studies of 125I-TU.-Tumourbearing mice, 3-12 animals in each group, received single i.p. injections of varying radiodoses of 1251-TU (Batch A) and were killed after 1, 4 and 7 days. Pieces of tissues from a number of organs and 2-3 tumour pieces were excised from each animal. The radioactivity was measured and calculated as the percentage of the given dose recovered per g of tissue (% g dose per g tissue; Table IA (Table  IB) .
Comparison between 125I-T U, 125I-PT U and Na125 I.-1251-TU (Batch B), 1251-PTU and Na125I were given i.p. in single doses at 400,000 ct/min/g body wt. The 1251-PTU animals were killed after 1, 4 and 7 days and the 1251-TU and Nal251 animals were killed after 4 days. Each group consisted of 3-5 animals (Table II) .
Studies on deiodination of 125I-TU in vivo.-The in vivo loss of 1251 from the 1251-TU was studied by comparing the thyroidal accumulation of radioactivity after 1251-TU and Nal25J administration respectively. Five animals were injected i.p. with Na125J or 125L-TU (400,000 ct/min/g body wt., Batch B) and killed after 4 days for necropsy and gamma scintillation counting.
The thyroid uptake (in % g dose per g tissue) of radioactivity after 1251-TU injection (Table II) was then reduced by our earlier value after 14C-thiouracil injection (Dencker et al., 1982) . This gives the approximate contribution of free 1251 to the thyroid radioactivity concentration after 1251-TU administration.
This accumulation of free 125I can then be compared to that obtained after 1251 injection as described above. The percentage deiodination can thus be easily calculated. As (Table IV) .
Uptake of 1251-TU and 125I-PTU vs 14C-TU in Harding-Passey melanoma cells in vitro.-Harding-Passey melanotic melanoma cells were grown in a medium containing 50 ml fetal calf serum, 450 ml RPMI 1640 (Flow Laboratories) 5 ml glutamine (0-2M) with streptomycin and penicillin added. The medium was exchanged every 2 days. After the cells had grown till confluency, 1251-TU (105 ct/min/ml, Batch B) or 1251-PTU (105 ct/min/ml) plus 14C-TU (105 disintegrations/ min/ml) was added to the medium (5 cultures each). The cultures were discontinued after 24 h. One ml of the growth medium from each culture was taken for gamma (1251) and liquid scintillation counting (14C) after addition of 10 ml of Instagel. The cultures were washed 4 times in fresh culture medium and then incubated with 0.25% trypsin and 0 02% Na-EDTA in PBS for 20 min to loosen the cells. The cells were counted in a Burker chamber. After centrifugation (4000 rev/min for 10 min), the radioactivity of the cells was measured, first the gamma activity (1251) and then, after dissolution of the cells in Soluene-100 (Packard), the beta-activity (14C). Specific quenching measurements were performed as described under Double isotope studies (above). The results are given in Table V .
Incorporation into melanin in vitro.-The simultaneous incorporation of 125I-TU and 14C-TU into melanin synthesized in vitro was studied both enzymatically (1) and by auto-oxidation (2):
(1) Fifty ,umol L-DOPA, 106 disinte- grations/min 1251-TU (Batch B) and 106 disintegrations/min 14C-TU were dissolved in 15 ml 1/15M phosphate buffer, pH 6-8. Five thousand units tyrosinase (Sigma) was then added. Air was bubbled through the reaction mixture for 40 h at room temperature, followed by the addition of 1 ml 12M HCI.
(2) This synthesis was performed as in (1) with two modifications: the pH of the phosphate buffer was kept at 8-0 and no tyrosinase was added.
The black precipitates (melanin) were collected by centrifugation (35,000 g for 10 min), and then washed 4 times with 10 ml distilled water. The first supernatant and the washing media were mixed and their total radioactivity was measured by gammacounting (1251-TU) and liquid scintillation counting (14C-TU). The melanins were freezedried and weighed and their content of radioactivity was then mesured (Table VI) .
Effects of thyroxine and potassium iodide (KI) on the 125I-TU distribution.-Melanomabearing mice were given either normal tap water or water containing thyroxine (20 jug/ml for 14 days) and KI (2 mg/ml for 3 days) before they were administered 125I-TU i.p. (22,900 ct/min/g body wt, Batch A). They were then killed after 1, 4 and 7 days (3 for each interval and treatment) and necropsied for gamma-scintillation counting (Table VII) . Two mice (1 control and 1 treated) received 125I-TU (115,000 ct/min/g body wt) i.p. and were killed after 4 days for autoradiography. As the combined treatment with KI and thyroxine indicated an effect not only on thyroid uptake of radioactivity but also on its distribution in other organs, it was decided to study the separate effects of the 2 treatments in non-tumour-bearing mice. Five animals were pretreated with KI (4 mg/ml) and 5 animals with thyroxine (40 ,ug/ml). Four animals had no pretreatment. All the mice were then injected with 400,000 ct/min/g body wt of 1251-TU (Batch B), killed after 4 days and necropsied for gamma-scintillation counting (Table VIII) . Table  IA , the 125I-TU was accumulated and retained in melanotic melanomas of mice in a similar way to thiouracil. Thus, at long survival intervals, when most of the drug was eliminated from the body, the tumour tissues had considerably higher concentrations of radioactivity than any other tissue except the thyroid. In the autoradiograms, the tumours showed a mottled pattern, indicating regional differences in the rate of incorporation. When tumour tissues were scraped off from whole-body sections where the autoradiograms had shown the highest accumulation, and the concentration in these areas was compared to that of liver and muscle of the same section, ratios of up to 22 and 778 respectively were obtained (Table IB) . Table II shows that 125I-PTU as well was accumulated in melanotic melanomas, although less so than 1251-TU. One reason for this could be a more rapid metabolic transformation or clearance from the body of 1251-PTU than was observed for 1251- Table II includes a group of mice that received Na125J. As can be seen, the radioactivity of most organs of these animals differed from those of the animals that received 125I-TU or 125J-PTU at the same survival interval, and in particular there was no apparent accumulation of 1251 in melanomas compared with other tissues. This indicates that most of the radioactivity after 1251-TU or 125I-PTU administration probably did not represent free 1251
RESULTS
As can be seen in the Figure and in
Administration of 1251-TU gave higher radioactivity concentrations in the thyroid than would have been expected if 125I-TU would accumulate in the thyroid to the same extent as we had earlier observed for 14C-labelled thiouracil (Dencker et al., 1982) . This could be due to partial deiodination of 125I-TU. In order to roughly calculate the percentage of the total 1251-TU dose that had been deiodinated after 4 days, we injected Na-125I or 1251-TU to groups of non-tumour-bearing mice (Table  III) . The thyroid radioactivity after 1251-TU dosing was considered to be due partly to free 125I, and partly to unchanged 1251 TU. We then subtracted from the total thyroidal radioactivity the expected 1251-TU activity (as calculated from our previous 14C-TU values). The rest should mainly represent free 1251.* This activity was approximately 14% of what was obtained after Na'251 administration and we may therefore assume that around 14% of the 1251-TU dose had been deiodinated within 4 days.
The somewhat lower organ and tumour radioactivity concentrations after 1251-TU administration in comparison with our previous 14C-thiouracil results and the partial deiodination in vivo prompted us to study 125I-TU and 14C-TU in the same animals (double-isotope study; Table IV ). There were considerable variations in the 1251/14C ratios when different organs were compared. With the exception of the thyroid, where the fraction of free 125-1 specifically accumulated, all organs had a lower 1251 than 14C radioactivity. In this respect, tumour and muscle have an intermediate position with a ratio of 0 35, the liver and kidney somewhat higher (ratios of 0-66 and 0-51 respectively) and lung and eye lower (0.05 and 0.15 respectively). The serum concentrations were too low to give reliable ratios. A comparison with does not indicate that free 1251 essentially contributred to the differences in the ratios of the various organs. Due to the variability of different organs in their uptake of 125I-TU and 14C-TU, the in vivo results could not unambiguously determine whether 125-TU was incorporated into melanin to the same extent as 14C-TU. When melanoma cells were grown in vitro for 24 h in a medium containing both 1251-TU and 14C-TU, the resulting 1251/14C ratio was more than doubled in the cells as compared to growing medium ( Table V) . The 125I-PTU concentration was only two-thirds of the 14C-TU when compared under the same conditions. The calculated ratio 1251-TU/1251-PTU in the cells was 5-6. Table VI shows that 1251-TU and 14C_ TU, when present together in a cell-free medium where melanin is synthetized from DOPA, are incorporated approximately to the same extent. This is true both when the melanin is formed by autooxidation and enzymatically through tyrosinase activity.
In a clinical perspective it is essential to bring down the accumulation of 1251-TU and free 1251 in the thyroid. Pretreatment of melanoma-bearing mice with thyroxine and KI essentially decreased the thyroidal accumulation of radioactivity after 1251-TU administration, without changing the concentration of radioactivity in the ttumours compared with non-treated animals (Table VII) . In the autoradiograms from pretreated animals, the thyroid concentration was usually at the level of the tumour areas with highest concentration. A considerable decrease in radioactivity was observed also in livers and kidneys, especially at 4 and 7 days, and this effect was studied in more detail in non-tumour-bearing mice (Table  VIII) . The results show that KI but especially thyroxine, when preadministered separately, decreased liver and kidney concentrations of radioactivity as measured 4 days after administration of 1251-TU. KI pretreatment was much rnore effective in decreasing the thyroid accumulation of radioactivity (probably mainly free 1251) than was thyroxine.
DISCUSSION
Our results indicate that iodo-thiouracil and -propylthiouracil, when present in the medium during formation of synthetic melanin (using DOPA as the main precursor), are incorporated into the melanin fornmed. This is also true for melanoma cells grown in vitro. 1251-TU, 14C-TU and 125I-PTU are taken up in such cells in this order. In a cell system, factors such as membrane passage of the compounds and their uptake into the cells are important in relation to the extent of the final incorporation, and it is possible that this explains the differences in uptake of these 3 compounds in our study.
If we consider the in vivo situation, a large number of additional factors are involved. The availability of the compound in the extracellular space around the tumour is then an additional important factor for the rate of incorporation. This is dependent on the serum concentration and the degree of proteinbinding in the plasma, which in turn depends on the metabolic transformation and excretion.
The in vivo double-isotope studies indicate that 125I-TU leaves the body more quickly than 14C-TU. This is partly due to deiodination of the 125I-TU, but most probably the intact molecule or metabolite(s) of it is excreted more rapidly. Consequently, the uptake in the melanomas, as a percentage of the dose given to the animal, was lower than that of 14C-TU, although the tumour/liver and tumour/ muscle ratios were in the same range for the two analogues.
The in vivo results of the experiments with 1251-PTU support the in vitro studies which indicated that less 1251-PTU accumulates in melanoma cells.
The use of a false precursor of melanin instead of the physiological ones (mainly tyrosine and DOPA) may appear circuitous. Both these show a relatively low specificity for melanin. Tyrosine, being an amino acid, is utilized in protein synthesis in all parts of the body, and in our studies (unpublished) very little iodotyrosine was incorporated into melanin in vivo. Meier et al. (1967) also failed to demonstrate an incorporation of radioactivity into melanomas after administration of 1251-labelled melanin precursors (5,6-diacetoxyindole). DOPA is taken up in endocrine organs like the adrenal medulla, in the pancreas and in gastric mucosa (Rosell et al., 1963) .
The localization in melanomas of polycyclic amines (mainly radioiodine-labelled quinolines) which are known to bind to preformed melanin, has been attempted with varying results (Potts, 1964; Beierwaltes et al., 1968; Blois, 1968; Walsh & Packer, 1971; Safi & Blanquet, 1973; Packer et al., 1975) . The most obvious disadvantage with this type of compound is that they bind strongly to the melanin of normal tissues, especially the eye. This may cause ocular damage at higher doses, or interfere with the radioactivity of an ocular melanoma if they are used to detect such tumours (Walsh & Packer, 1971) . Quinoline derivatives also accumulate in a number of endocrine cell systems, as well as in the kidney and bone marrow, and show a long-term retention in the body (Dencker et al., 1975 (Dencker et al., , 1976 .
The main advantage of 1251-TU is thus that it is not accumulated in the preformed melanin (especially in the eye), and will not be accumulated and retained in any other tissue of the body. The only exception is the thyroid, where the 1251-TU as well as free 1251-(formed after the partial deiodination of the 1251-TU) will be markedly concentrated.
However, as shown here, this accumulation was essentially eliminated by proper pretreatment either with KI, thyroxine or the combination of the two. As there is adequate clinical experience in the problem of radioiodine uptake in the thyroid, we feel that iodothiouracil, labelled with 1311 or 123J, may be ready for clinical evaluation in the detection of melanotic melanomas. If it turns out to be as selective for melanomas in man as it is in experimental animals, it may be tested also as a therapeutic agent provided high enough doses can be given to patients.
